Skip to content
2000
Volume 25, Issue 3
  • ISSN: 1566-5240
  • E-ISSN: 1875-5666

Abstract

Long non-coding RNAs (lncRNAs) are transcribed RNA molecules longer than 200 nucleotides in length that have no protein-coding potential. They are able to react with DNA, RNA, and protein. Hence they involve in regulating gene expression at the epigenetic, transcriptional, post-transcriptional, and translational levels. LncRNAs have been proven to play an important role in human malignancies and prognostic outcomes. In this review, we will comprehensively and functionally discuss the role of a novel identified lncRNA, namely lncRNA WAPPH located on human chromosome 2q13, in various cancers. Increasing research studies have shown that lncRNA AWPPH is deregulated in different malignancies, including breast cancer, gastric cancer, colorectal cancer, ovarian cancer, bladder cancer, leukemia, and others. LncRNA WAPPH serves as an oncogene in tumorigenesis and the development of cancer. Moreover, lncRNA AWPPH is involved in numerous biological processes of solid and blood cancers. Taken together, based on our scrutiny analysis, lncRNA AWPPH can be regarded as a putative biomarker for diagnosis or therapeutic target in human malignancies.

Loading

Article metrics loading...

/content/journals/cmm/10.2174/1566524023666230816163031
2025-03-01
2025-07-08
Loading full text...

Full text loading...

References

  1. AboyansV. CollaboratorsC.D. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013.Lancet2015385996311717110.1016/S0140‑6736(14)61682‑2 25530442
    [Google Scholar]
  2. BrayF. FerlayJ. SoerjomataramI. SiegelR.L. TorreL.A. JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.201868639442410.3322/caac.21492 30207593
    [Google Scholar]
  3. JiangM-C. NiJ-J. CuiW-Y. WangB-Y. ZhuoW. Emerging roles of lncRNA in cancer and therapeutic opportunities.Am. J. Cancer Res.20199713541366 31392074
    [Google Scholar]
  4. SheykhhasanM. AhmadyousefiY. SeyedebrahimiR. DLX6-AS1: A putative lncRNA candidate in multiple human cancers.Expert Rev. Mol. Med.202123e1710.1017/erm.2021.17 34823630
    [Google Scholar]
  5. HosseiniN.F. ManoochehriH. KhoeiS.G. SheykhhasanM. The functional role of long non-coding RNA UCA1 in human multiple cancers: A review study.Curr. Mol. Med.20212129611010.2174/18755666MTA3oNDYb1 32560605
    [Google Scholar]
  6. HuangT. AlvarezA. HuB. ChengS.Y. Noncoding RNAs in cancer and cancer stem cells.Chin. J. Cancer2013321158259310.5732/cjc.013.10170 24206916
    [Google Scholar]
  7. AkhbariM.H. ZafariZ. SheykhhasanM. Competing endogenous RNAs (ceRNAs) in colorectal cancer: A review.Expert Rev. Mol. Med.202224e2710.1017/erm.2022.21 35748050
    [Google Scholar]
  8. SheykhhasanM. FazaeliH. SheikholeslamiA. GhasemianF. AminiE. The emerging role of LncRNA FENDRR in multiple cancers: A review.Curr. Mol. Med.202323760662910.2174/1566524022666220509122505 35579154
    [Google Scholar]
  9. SheykhhasanM. TanzadehpanahH. Ahmadieh YazdiA. FLVCR1-AS1 and FBXL19-AS1: Two putative lncRNA candidates in multiple human cancers.Noncoding RNA202291110.3390/ncrna9010001 36649030
    [Google Scholar]
  10. WangH. WuM. LuY. LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt/β-catenin signaling.Aging201911176657667310.18632/aging.102164 31484163
    [Google Scholar]
  11. SongZ. DuJ. ZhouL. SunB. lncRNA AWPPH promotes proliferation and inhibits apoptosis of non small cell lung cancer cells by activating the Wnt/β catenin signaling pathway.Mol. Med. Rep.20191954425443210.3892/mmr.2019.10089 30942396
    [Google Scholar]
  12. MitraR. ChenX. GreenawaltE.J. Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition.Nat. Commun.201781160410.1038/s41467‑017‑01781‑0 29150601
    [Google Scholar]
  13. YangQ. XuE. DaiJ. A novel long noncoding RNA AK001796 acts as an oncogene and is involved in cell growth inhibition by resveratrol in lung cancer.Toxicol. Appl. Pharmacol.20152852798810.1016/j.taap.2015.04.003 25888808
    [Google Scholar]
  14. TsaiM.C. ManorO. WanY. Long noncoding RNA as modular scaffold of histone modification complexes.Science2010329599268969310.1126/science.1192002 20616235
    [Google Scholar]
  15. NaganoT. FraserP. No-nonsense functions for long noncoding RNAs.Cell2011145217818110.1016/j.cell.2011.03.014 21496640
    [Google Scholar]
  16. IyerM.K. NiknafsY.S. MalikR. The landscape of long noncoding RNAs in the human transcriptome.Nat. Genet.201547319920810.1038/ng.3192 25599403
    [Google Scholar]
  17. WuH ShangX ShiY Genetic variants of lncRNA HOTAIR and risk of epithelial ovarian cancer among Chinese women.Oncotarget 2106727410475210.18632/oncotarget.8535 27166268
    [Google Scholar]
  18. Alvarez-DominguezJ.R. LodishH.F. Emerging mechanisms of long noncoding RNA function during normal and malignant hematopoiesis.Blood2017130181965197510.1182/blood‑2017‑06‑788695 28928124
    [Google Scholar]
  19. StatelloL. GuoC.J. ChenL.L. HuarteM. Gene regulation by long non-coding RNAs and its biological functions.Nat. Rev. Mol. Cell Biol.20212229611810.1038/s41580‑020‑00315‑9 33353982
    [Google Scholar]
  20. RodriguezA. Griffiths-JonesS. AshurstJ.L. BradleyA. Identification of mammalian microRNA host genes and transcription units.Genome Res.20041410a1902191010.1101/gr.2722704 15364901
    [Google Scholar]
  21. YanL. ZhouJ. GaoY. Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation.Oncogene201534233076308410.1038/onc.2014.236 25088204
    [Google Scholar]
  22. GaoY. MengH. LiuS. LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b.Hum. Mol. Genet.201524384185210.1093/hmg/ddu502 25292198
    [Google Scholar]
  23. ChaiY. LiuJ. ZhangZ. LiuL. HuR-regulated lnc RNA NEAT 1 stability in tumorigenesis and progression of ovarian cancer.Cancer Med.2016571588159810.1002/cam4.710 27075229
    [Google Scholar]
  24. WorkuT. BhattaraiD. AyersD. Long non-coding RNAs: The new horizon of gene regulation in ovarian cancer.Cell. Physiol. Biochem.201744394896610.1159/000485395 29179183
    [Google Scholar]
  25. LuanX. WangY. LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p.J. Gynecol. Oncol.2018296e9510.3802/jgo.2018.29.e95 30207103
    [Google Scholar]
  26. CaoX. XuJ. YueD. LncRNA-SNHG16 predicts poor prognosis and promotes tumor proliferation through epigenetically silencing p21 in bladder cancer.Cancer Gene Ther.2018251-2101710.1038/s41417‑017‑0006‑x 29234154
    [Google Scholar]
  27. ZhaoL. HanT. LiY. The IncRNA SNHG5/miR‐32 axis regulates gastric cancer cell proliferation and migration by targeting KLF4.FASEB J.201731389390310.1096/fj.201600994R 27871067
    [Google Scholar]
  28. GuptaR.A. ShahN. WangK.C. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis.Nature201046472911071107610.1038/nature08975 20393566
    [Google Scholar]
  29. LiuX. SunM. NieF. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer.Mol. Cancer20141319210.1186/1476‑4598‑13‑92 24775712
    [Google Scholar]
  30. JiaoJ. ZhangS. Long non coding RNA MEG 3 suppresses gastric carcinoma cell growth, invasion and migration via EMT regulation.Mol. Med. Rep.20192032685269310.3892/mmr.2019.10515 31524253
    [Google Scholar]
  31. ZhuL. WangA. GaoM. DuanX. LiZ. LncRNA MIR4435-2HG triggers ovarian cancer progression by regulating miR-128-3p/CKD14 axis.Cancer Cell Int.202020114510.1186/s12935‑020‑01227‑6 32377170
    [Google Scholar]
  32. DongX. YangZ. YangH. LiD. QiuX. Long non-coding RNA MIR4435-2HG promotes colorectal cancer proliferation and metastasis through miR-206/YAP1 axis.Front. Oncol.20201016010.3389/fonc.2020.00160 32154166
    [Google Scholar]
  33. KongQ. LiangC. JinY. The lncRNA MIR4435-2HG is upregulated in hepatocellular carcinoma and promotes cancer cell proliferation by upregulating miRNA-487a.Cell. Mol. Biol. Lett.20192412610.1186/s11658‑019‑0148‑y 30988676
    [Google Scholar]
  34. LiuB. PanC.F. MaT. Long non-coding RNA AK001796 contributes to cisplatin resistance of non-small cell lung cancer.Mol. Med. Rep.20171644107411210.3892/mmr.2017.7081 29067469
    [Google Scholar]
  35. DengL. ChiY. LiuL. HuangN. WangL. WuJ. LINC00978 predicts poor prognosis in breast cancer patients.Sci. Rep.2016613793610.1038/srep37936 27897214
    [Google Scholar]
  36. KeD. LiH. ZhangY. The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer.Oncotarget2017813215162152510.18632/oncotarget.15628 28423525
    [Google Scholar]
  37. FuM. HuangZ. ZangX. Long noncoding RNA LINC 00978 promotes cancer growth and acts as a diagnostic biomarker in gastric cancer.Cell Prolif.2018511e1242510.1111/cpr.12425 29271006
    [Google Scholar]
  38. HartanaC.A. RassadkinaY. GaoC. Long noncoding RNA MIR4435-2HG enhances metabolic function of myeloid dendritic cells from HIV-1 elite controllers.J. Clin. Invest.20211319e14613610.1172/JCI146136 33938445
    [Google Scholar]
  39. LinT. WuN. WangL. ZhangR. PanR. ChenY.F. Inhibition of chondrocyte apoptosis in a rat model of osteoarthritis by exosomes derived from miR 140 5p overexpressing human dental pulp stem cells.Int. J. Mol. Med.2020473710.3892/ijmm.2020.4840 33448311
    [Google Scholar]
  40. ZhangS. LiC. LiuJ. Fusobacterium nucleatum promotes epithelial‐mesenchymal transiton through regulation of the lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway.FEBS J.2020287184032404710.1111/febs.15233 31997506
    [Google Scholar]
  41. ShenH. SunB. YangY. MIR4435-2HG regulates cancer cell behaviors in oral squamous cell carcinoma cell growth by upregulating TGF-β1.Odontology2020108455355910.1007/s10266‑020‑00488‑x 32016787
    [Google Scholar]
  42. ChenM. ZhengY. XieJ. ZhenE. ZhouX. Integrative profiling analysis identifies the oncogenic long noncoding RNA DUXAP8 in oral cancer.Anticancer Drugs202031879279810.1097/CAD.0000000000000936 32304409
    [Google Scholar]
  43. LiuB. PanC.F. YaoG.L. WeiK. XiaY. ChenY.J. The long non-coding RNA AK001796 contributes to tumor growth via regulating expression of p53 in esophageal squamous cell carcinoma.Cancer Cell Int.20181813810.1186/s12935‑018‑0537‑8 29568233
    [Google Scholar]
  44. ZongM.Z. ShaoQ. AnX.S. Expression and prognostic significance of long noncoding RNA AK001796 in esophageal squamous cell carcinoma.Eur. Rev. Med. Pharmacol. Sci.2019231181186 30657559
    [Google Scholar]
  45. GaoL.F. LiW. LiuY.G. ZhangC. GaoW.N. WangL. Inhibition of MIR4435-2HG on invasion, migration, and EMT of gastric carcinoma cells by mediating MiR-138-5p/Sox4 axis.Front. Oncol.20211166128810.3389/fonc.2021.661288 34532282
    [Google Scholar]
  46. MiaoY. SuiJ. XuS.Y. LiangG.Y. PuY.P. YinL.H. Comprehensive analysis of a novel four-lncRNA signature as a prognostic biomarker for human gastric cancer.Oncotarget2017843750077502410.18632/oncotarget.20496 29088841
    [Google Scholar]
  47. BuJ.Y. LvW.Z. LiaoY.F. XiaoX.Y. LvB.J. RETRACTED: Long non-coding RNA LINC00978 promotes cell proliferation and tumorigenesis via regulating microRNA-497/NTRK3 axis in gastric cancer.Int. J. Biol. Macromol.20191231106111410.1016/j.ijbiomac.2018.11.162 30452981
    [Google Scholar]
  48. HuangZ. LiangW. PanL. ZhangP. Expression of serum LINC00978 in gastric cancer patients and its clinical significance.Chin J Clin Lab Sci201712575578
    [Google Scholar]
  49. LiL. KouJ. ZhongB. Up-regulation of long non-coding RNA AWPPH inhibits proliferation and invasion of gastric cancer cells via miR-203a/DKK2 axis.Hum. Cell201932449550310.1007/s13577‑019‑00277‑x 31489578
    [Google Scholar]
  50. LiC ChenZ GaoJ MIR4435-2HG in exosomes promotes gastric carcinogenesis by inducing M2 polarization in macrophages.Front Oncol 202212101774510.3389/fonc.2022.101774536483041
    [Google Scholar]
  51. OuyangW. RenL. LiuG. ChiX. WeiH. LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer.PeerJ20197e668310.7717/peerj.6683 30972258
    [Google Scholar]
  52. ShenM.Y. ZhouG.R. -Y ZhangZ. LncRNA MIR4435-2HG contributes into colorectal cancer development and predicts poor prognosis.Eur. Rev. Med. Pharmacol. Sci.202024417711777 32141545
    [Google Scholar]
  53. GhasemiT. Khalaj-KondoriM. Hosseinpour feiziMA AsadiP. Aberrant expression of lncRNAs SNHG6, TRPM2-AS1, MIR4435‐2HG, and hypomethylation of TRPM2-AS1 promoter in colorectal cancer.Cell Biol. Int.202145122464247810.1002/cbin.11692 34431156
    [Google Scholar]
  54. WuM. LiW. HuangF. Comprehensive analysis of the expression profiles of long non-coding RNAs with associated ceRNA network involved in the colon cancer staging and progression.Sci. Rep.2019911691010.1038/s41598‑019‑52883‑2 31729423
    [Google Scholar]
  55. ChenJ. SongY. LiM. Comprehensive analysis of ceRNA networks reveals prognostic lncRNAs related to immune infiltration in colorectal cancer.BMC Cancer202121125510.1186/s12885‑021‑07995‑2 33750326
    [Google Scholar]
  56. XingX.L. ZhangT. YaoZ.Y. Immune-related gene expression analysis revealed three lncRNAs as prognostic factors for colon cancer.Front. Genet.20211269005310.3389/fgene.2021.690053 34306030
    [Google Scholar]
  57. GhasemianM. RajabibazlM. MirfakhraieR. RazaviA.E. SadeghiH. Long noncoding RNA LINC00978 acts as a potential diagnostic biomarker in patients with colorectal cancer.Exp. Mol. Pathol.202112210466610.1016/j.yexmp.2021.104666 34273360
    [Google Scholar]
  58. BaiJ. XuJ. ZhaoJ. ZhangR. Downregulation of lncRNA AWPPH inhibits colon cancer cell proliferation by downregulating GLUT 1.Oncol. Lett.20191822007201210.3892/ol.2019.10515 31423271
    [Google Scholar]
  59. LuoP. WuS. JiK. LncRNA MIR4435-2HG mediates cisplatin resistance in HCT116 cells by regulating Nrf2 and HO-1.PLoS One20201511e022303510.1371/journal.pone.0223035 33232319
    [Google Scholar]
  60. YuM. YiZ. ChenS. ChenX. XieX.J. MIR4435-2HG, miR-125b-5p, and Sema4D axis affects the aggressiveness of colorectal cancer cells.Folia Histochem. Cytobiol.202260219120210.5603/FHC.a2022.0018 35730423
    [Google Scholar]
  61. YuH. ChenC. HanF. Long noncoding RNA MIR4435-2HG suppresses colorectal cancer initiation and progression by reprogramming neutrophils.Cancer Immunol. Res.20221091095111010.1158/2326‑6066.CIR‑21‑1011
    [Google Scholar]
  62. ChenW. ChenY. LiuL. Comprehensive analysis of immune infiltrates of ferroptosis-related long noncoding RNA and prediction of colon cancer patient prognoses.J. Immunol. Res.20222022948062810.1155/2022/9480628 35265722
    [Google Scholar]
  63. ZhuD. GuoP. JinX.Y. Long-chain non-coding RNA MIR4435-2HG expression correlates with size of intestinal polyps in children and with metastasis of colon cancer.Anticancer Res.202242104707471410.21873/anticanres.15975 36191994
    [Google Scholar]
  64. ShenX. DingY. LuF. YuanH. LuanW. Long noncoding RNA MIR4435-2HG promotes hepatocellular carcinoma proliferation and metastasis through the miR-22-3p/YWHAZ axis.Am. J. Transl. Res.2020121063816394 33194037
    [Google Scholar]
  65. WangB. TangD. ZhangZ. WangZ. Identification of aberrantly expressed lncRNA and the associated TF‐mRNA network in hepatocellular carcinoma.J. Cell. Biochem.202012121491150310.1002/jcb.29384 31498488
    [Google Scholar]
  66. BaiY. LinH. ChenJ. WuY. YuS. Identification of prognostic glycolysis-related lncRNA signature in tumor immune microenvironment of hepatocellular carcinoma.Front. Mol. Biosci.2021864508410.3389/fmolb.2021.645084 33968985
    [Google Scholar]
  67. ZhangQ. ChengS. CaoL. YangJ. WangY. ChenY. LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway.Biosci. Rep.2020403BSR2019279010.1042/BSR20192790 32077915
    [Google Scholar]
  68. HanQ.L. ChenB.T. ZhangK.J. XiaS.T. ZhongW.W. ZhaoZ.M. The long non-coding RNA AK001796 contributes to poor prognosis and tumor progression in hepatocellular carcinoma.Eur. Rev. Med. Pharmacol. Sci.201923520132019 30915744
    [Google Scholar]
  69. ZhaoX. LiuY. YuS. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.Biochim. Biophys. Acta Mol. Basis Dis.2017186371805181610.1016/j.bbadis.2017.04.014 28428004
    [Google Scholar]
  70. LiS HuX YuS Hepatic stellate cell-released CXCL1 aggravates HCC malignant behaviors through the MIR4435- 2HG/miR-506-3p/TGFB1 axis.Cancer Sci202211425042010.1111/cas.15605.36169092
    [Google Scholar]
  71. ZhuY. LiB. XuG. HanC. XingG. lncRNA MIR4435 2HG promotes the progression of liver cancer by upregulating B3GNT5 expression.Mol. Med. Rep.2022251111 34859256
    [Google Scholar]
  72. QianH. ChenL. HuangJ. The lncRNA MIR4435-2HG promotes lung cancer progression by activating β-catenin signalling.J. Mol. Med.201896875376410.1007/s00109‑018‑1654‑5 29872866
    [Google Scholar]
  73. YangM. HeX. HuangX. WangJ. HeY. WeiL. LncRNA MIR4435-2HG-mediated upregulation of TGF‐β1 promotes migration and proliferation of nonsmall cell lung cancer cells.Environ. Toxicol.202035558259010.1002/tox.22893 31875359
    [Google Scholar]
  74. TangL. WangT. ZhangY. Long non-coding RNA AWPPH promotes postoperative distant recurrence in resected non-small cell lung cancer by upregulating transforming growth factor beta 1 (TGF-β1).Med. Sci. Monit.2019252535254110.12659/MSM.912876 30953582
    [Google Scholar]
  75. HuoY. LiA. WangZ. LncRNA AWPPH participates in the metastasis of non small cell lung cancer by upregulating TGF β1 expression.Oncol. Lett.20191844246425210.3892/ol.2019.10754 31516619
    [Google Scholar]
  76. WuD. QinB.Y. QiX.G. HongL.L. ZhongH.B. HuangJ.Y. LncRNA AWPPH accelerates the progression of non-small cell lung cancer by sponging miRNA-204 to upregulate CDK6.Eur. Rev. Med. Pharmacol. Sci.202024842814287 32373964
    [Google Scholar]
  77. GuoD. LiuF. ZhangL. Long non-coding RNA AWPPH enhances malignant phenotypes in nasopharyngeal carcinoma via silencing PTEN through interacting with LSD1 and EZH2.Biochem. Cell Biol.202199219520210.1139/bcb‑2019‑0497 32663416
    [Google Scholar]
  78. ChenD. TangP. WangY. Downregulation of long non coding RNA MR4435 2HG suppresses breast cancer progression via the Wnt/β catenin signaling pathway.Oncol. Lett.202121537310.3892/ol.2021.12634 33777197
    [Google Scholar]
  79. KumarM DeVauxRS ShenJJ LncRNA AK001796 as a therapeutic target in aggressive breast cancers.Cancer Res201676S 141598
    [Google Scholar]
  80. WangK. LiX. SongC. LiM. LncRNA AWPPH promotes the growth of triple-negative breast cancer by up-regulating frizzled homolog 7 (FZD7).Biosci. Rep.2018386BSR2018122310.1042/BSR20181223 30333256
    [Google Scholar]
  81. LiuA.N. QuH.J. GongW.J. XiangJ.Y. YangM.M. ZhangW. LncRNA AWPPH and miRNA‐21 regulates cancer cell proliferation and chemosensitivity in triple‐negative breast cancer by interacting with each other.J. Cell. Biochem.20191209148601486610.1002/jcb.28747 31033015
    [Google Scholar]
  82. KeJ. WangQ. ZhangW. NiS. MeiH. LncRNA MIR4435-2HG promotes proliferation, migration, invasion and epithelial mesenchymal transition via targeting miR-22-3p/TMEM9B in breast cancer.Am. J. Transl. Res.202214854415454 36105009
    [Google Scholar]
  83. WangR. LiuL. JiaoJ. GaoD. Knockdown of MIR4435-2HG suppresses the proliferation, migration and invasion of cervical cancer cells via regulating the miR-128-3p/MSI2 axis in vitro.Cancer Manag. Res.2020128745875610.2147/CMAR.S265545 33061572
    [Google Scholar]
  84. BrettM.R. BrettM.R. JenniferB.P. ThomasA.S. JenniferB.P. ThomasA.S. Epidemiology of ovarian cancer: A review.Cancer Biol. Med.201714193210.20892/j.issn.2095‑3941.2016.0084 28443200
    [Google Scholar]
  85. GongJ. XuX. ZhangX. ZhouY. LncRNA MIR4435-2HG is a potential early diagnostic marker for ovarian carcinoma.Acta Biochim. Biophys. Sin.201951995395910.1093/abbs/gmz085 31435668
    [Google Scholar]
  86. YuG. WangW. DengJ. DongS. LncRNA AWPPH promotes the proliferation, migration and invasion of ovarian carcinoma cells via activation of the Wnt/β catenin signaling pathway.Mol. Med. Rep.20191953615362110.3892/mmr.2019.10029 30896797
    [Google Scholar]
  87. ZhuF. ZhangX. YuQ. LncRNA AWPPH inhibits SMAD4 via EZH2 to regulate bladder cancer progression.J. Cell. Biochem.201811964496450510.1097/MD.0000000000012399
    [Google Scholar]
  88. WangW. XuZ. WangJ. ChenR. LINC00978 promotes bladder cancer cell proliferation, migration and invasion by sponging miR 4288.Mol. Med. Rep.20192021866187210.3892/mmr.2019.10395 31257499
    [Google Scholar]
  89. HuZ. MaS. SunY. LongG. ChenK.J.G. Identification of long non-coding RNA MIR4435-2HG as a prognostic biomarker in bladder cancer.Genes2022138146210.3390/genes13081462 36011373
    [Google Scholar]
  90. YangT LiY WangG lncRNA MIR4435-2HG accelerates the development of bladder cancer through enhancing IQGAP3 and CDCA5 expression.Biomed Res Int 20222022385824910.1155/2022/3858249.35993042
    [Google Scholar]
  91. VuongL. KotechaR.R. VossM.H. HakimiA.A. Tumor microenvironment dynamics in clear-cell renal cell carcinoma.Cancer Discov.20199101349135710.1158/2159‑8290.CD‑19‑0499 31527133
    [Google Scholar]
  92. ZhaiW. SunY. JiangM. Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia.Oncogene201635374866488010.1038/onc.2016.19 26973243
    [Google Scholar]
  93. SonpavdeG. ChoueiriT.K. EscudierB. Sequencing of agents for metastatic renal cell carcinoma: Can we customize therapy?Eur. Urol.201261230731610.1016/j.eururo.2011.10.032 22055147
    [Google Scholar]
  94. ZhuK. MiaoC. TianY. lncRNA MIR4435‐2HG promoted clear cell renal cell carcinoma malignant progression via miR‐513a‐5p/KLF6 axis.J. Cell. Mol. Med.20202417100131002610.1111/jcmm.15609 33460239
    [Google Scholar]
  95. XingP. WangY. ZhangL. MaC. LuJ. Knockdown of lncRNA MIR4435-2HG and ST8SIA1 expression inhibits the proliferation, invasion and migration of prostate cancer cells in vitro and in vivo by blocking the activation of the FAK/AKT/β-catenin signaling pathway.Int. J. Mol. Med.20214769310.3892/ijmm.2021.4926 33846784
    [Google Scholar]
  96. ZhangH. MengH. HuangX. LncRNA MIR4435 2HG promotes cancer cell migration and invasion in prostate carcinoma by upregulating TGF-β1.Oncol. Lett.20191844016402110.3892/ol.2019.10757 31516603
    [Google Scholar]
  97. XuH. ZhangB. YangY. LncRNA MIR4435‐2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR‐1224‐5p/TGFBR2 axis.J. Cell. Mol. Med.202024116362637210.1111/jcmm.15280 32319715
    [Google Scholar]
  98. ZhangT. WangF. LiaoY. YuanL. ZhangB. LncRNA AWPPH promotes the invasion and migration of glioma cells through the upregulation of HIF1α.Oncol. Lett.20191866781678610.3892/ol.2019.11018 31807187
    [Google Scholar]
  99. DaiB. XiaoZ. MaoB. lncRNA AWPPH promotes the migration and invasion of glioma cells by activating the TGF-β pathway.Oncol. Lett.20191865923592910.3892/ol.2019.10918 31788066
    [Google Scholar]
  100. LiZ. TanH. ZhaoW. Integrative analysis of DNA methylation and gene expression profiles identifies MIR4435-2HG as an oncogenic lncRNA for glioma progression.Gene201971514401210.1016/j.gene.2019.144012 31357021
    [Google Scholar]
  101. ShenW. ZhangJ. PanY. JinY. LncRNA MIR4435‐2HG functions as a ceRNA against miR 125a 5p and promotes neuroglioma development by upregulating TAZ.J. Clin. Lab. Anal.20213512e2406610.1002/jcla.24066 34714963
    [Google Scholar]
  102. RothermundtC. SeddonB.M. DileoP. Follow-up practices for high-grade extremity Osteosarcoma.BMC Cancer201616130110.1186/s12885‑016‑2333‑y 27154292
    [Google Scholar]
  103. LiC. WangF. WeiB. WangL. KongD. LncRNA AWPPH promotes osteosarcoma progression via activation of Wnt/β-catenin pathway through modulating miR-93-3p/FZD7 axis.Biochem. Biophys. Res. Commun.201951431017102210.1016/j.bbrc.2019.04.203 31092328
    [Google Scholar]
  104. DingW. WuD. JiF. ZhangH. Inhibition of long non-coding RNA-AWPPH decreases osteosarcoma cell proliferation, migration and invasion.Oncol. Lett.20191855055506210.3892/ol.2019.10898 31612016
    [Google Scholar]
  105. RothenbergS.M. EllisenL.W. The molecular pathogenesis of head and neck squamous cell carcinoma.J. Clin. Invest.201212261951195710.1172/JCI59889 22833868
    [Google Scholar]
  106. WangS. ChenX. QiaoT. Long non-coding RNA-MIR4435 2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR-383-5p/RBM3 axis.Oncol. Rep.20214569910.3892/or.2021.8050 33846802
    [Google Scholar]
  107. LiX. SongF. SunH. Long non-coding RNA AWPPH interacts with ROCK2 and regulates the proliferation and apoptosis of cancer cells in pediatric T-cell acute lymphoblastic leukemia.Oncol. Lett.2020205110.3892/ol.2020.12102 32973953
    [Google Scholar]
  108. CaiZ. ZhangC. KotzinJ.J. WilliamsA. Henao-MejiaJ. KapurR. Role of lncRNA Morrbid in PTPN11(Shp2)E76K-driven juvenile myelomonocytic leukemia.Blood Adv.20204143246325110.1182/bloodadvances.2020002123 32697817
    [Google Scholar]
  109. CaiZ. AguileraF. RamdasB. Targeting Bim via a lncRNA morrbid regulates the survival of preleukemic and leukemic cells.Cell Rep.2020311210781610.1016/j.celrep.2020.107816 32579941
    [Google Scholar]
  110. CaiZ. LuX. ZhangC. Hyperglycemia cooperates with Tet2 heterozygosity to induce leukemia driven by proinflammatory cytokine-induced lncRNA Morrbid.J. Clin. Invest.20211311e14070710.1172/JCI140707 33090974
    [Google Scholar]
  111. ZhangC. YaoK. ZhangJ. Long noncoding RNA MALAT1 promotes colorectal cancer progression by acting as a ceRNA of miR-508-5p to regulate RAB14 expression.BioMed Res. Int.2020202011210.1155/2020/4157606 33344634
    [Google Scholar]
  112. JiangD. XuL. NiJ. ZhangJ. CaiM. ShenL. Functional polymorphisms in LncRNA HOTAIR contribute to susceptibility of pancreatic cancer.Cancer Cell Int.20191914710.1186/s12935‑019‑0761‑x 30867650
    [Google Scholar]
  113. FanC. YuanQ. LiuG. Long non-coding RNA MALAT1 regulates oxaliplatin-resistance via miR-324-3p/ADAM17 axis in colorectal cancer cells.Cancer Cell Int.202020147310.1186/s12935‑020‑01549‑5 33005106
    [Google Scholar]
/content/journals/cmm/10.2174/1566524023666230816163031
Loading
/content/journals/cmm/10.2174/1566524023666230816163031
Loading

Data & Media loading...


  • Article Type:
    Review Article
Keyword(s): AWPPH; Cancer biomarker; diagnosis; long non-coding RNA; neoplasm; therapeutic
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test